Global Non-opioid Pain Patch Market: Need for Non-addictive Chronic Pain Treatment to Foster Growth
Global Non-opioid Pain Patch Market: Need for Non-addictive Chronic Pain Treatment to Foster Growth
Researchers have prioritized the search for non-opioid drugs with escalating rates of opioid addiction. For years, physicians had been providing an aggressive treatment for chronic treatment resulting in narcotic-addiction among patients. However, the healthcare industry is no longer marrying the concept of pain relief with narcotic analgesics. Medical pain-management as a whole is drifting away from addictive procedures or treatments towards evidence-based treatments using non-opioid analgesics.
Read Report Overview - https://www.transparencymarketresearch.com/non-opioid-pain-patch-market.html
The sharp rise in the number of overdose deaths only echoes the magnitude of the crisis caused by the opioid epidemic. According to the World Health Organization, 27 Mn people suffered from opioid disorders in 2016. Overdose deaths accounted for around a third and a half of all the drug-related deaths.
The rising popularity of non-opioids as the “analgesics of the future” and efforts focused on tackling the crisis of “opioid epidemic” calls for a need to conduct an in-depth analysis of the non-opioid pain patch market. In its latest offering, Transparency Market Research talks about how the changes in healthcare trends and consumer demographics have impacted the market’s evolution.non opioid pain patch market
A Walk through the Evolutionary Timeline
As the consumers realized the ill-effects of opioid treatment, companies manufacturing and marketing these drugs faced public backlash. This acted as a stepping stone for the development of new non-opioid treatments which have redefined the non-opioid treatment market’s growth. In a bid to promote the use of non-opioid analgesics, the U.S. Food and Drug Administration (FDA) launched a campaign called the “innovation challenge”. It was aimed at the development of medical devices that could combat opioid use disorder.
The non-opioid pain match treatment market has come a long way from the development of the first patch product for PHN treatment in 2013 to the launch of OTC water-free lidocaine patch in March 2016. Furthermore, in February 2018, Tremeau Pharmaceuticals, Inc., closed the equity raise of $5.2 Mn to fund non-opioid treatments for rare diseases.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=26168
With the escalating new developments, the global non-opioid pain patch market is poised to rise from its initial valuation of US$ 3,750 Mn in 2015 to reach US$ 4,983.3 Mn in 2024. However, the high popularity of oral pain relief drugs due to their ability to mitigate pain in a short duration may act a stumbling block in the non-opioid pain patch market.
Trends Causing a Stir in the Non-opioid Pain Patch Market
Rising Popularity of Transdermal Drug Delivery
Transdermal delivery despite being an unexplored aspect of drug delivery is gradually entering the league of blockbuster drugs. Capitalizing on this riveting trend, non-opioid drug manufacturers are developing transdermal non-opioid painkiller patches. Moreover, the Food and Drug Administration is keen on approving transdermal drugs because of their efficacy in reducing postoperative pain. For instance, in March 2018, the FDA approved the non-opioid painkiller patch developed by Sorrento. Market players are not only launching new non-opioids but relaunching high-selling NSAIDs as into transdermal drug delivery systems.
Replacement of Existing Pain Patches with Next Gen Patches
In a bid to enhance the efficiency of the pain patch treatment, leading players are concentrating their efforts on upgrading the existing pain patches or replacing them with next-generation pain patches. This trend of introducing the existing drug with a better design has helped manufacturers garner considerable attention from the physicians and the patients. One such example of upgradation of pain patches is the study conducted by SCILEX Pharmaceuticals Inc., for the development of ZTlido, an anhydrous patch created using the patented technology. The development of such trailblazing products has amplified the adoption of non-opioid pain patches for the treatment of chronic pain.
Request for Analysis of COVID-19 Impact on Non-opioid Pain Patch Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26168
Key Winning Imperatives
Development of Personalized Non-opioid Pain Patches
Personalized medicines have taken the medical industry by a storm with soaring number of drug manufacturers tailoring the medicines as per the patient’s needs. Banking on the rising demand for “tailored medicine”, manufacturers are relying on patient genotyping to develop personalized pain patches for the patients. Following the same trends, Assurex Health, Inc. is working on introducing a genomics test to check the suitability of pain patches. This move is also aimed at developing solution for chronic pain with considerably low side effects. This incorporation of pharmacogenomics in the non-opioid pain patch unlocks a major growth opportunity for the market players.
Building Alliances with Leading Hospitals
According to TMR’s study, consumers are most likely to buy non-opioid drugs from hospital pharmacies, making it the most preferred distribution channel for the manufacturers. Hospital pharmacies accounted for 48.3% of the non-opioid pain patch market’s share in 2016. As a result, manufacturers are building strong alliances with the leading hospitals to gain access to their customer base.
Players are also gradually moving towards online sales channels due to the improvements in the electronic payment technology. Consumer interest is gradually shifting towards online pharmacies due to the extensive range of medications available online and transparency offered in terms of prices.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=26168
A Walk through the Competition Landscape
Market players in the non-opioid pain patch market share a moderate rivalry as the market is still in its nascent stage. Although the number of market players is less, they have remarkably high global reach due to strong brand identities. The top three players in the market including Hisamitsu
Pharmaceutical Co., Inc., Acorda Therapeutics, Inc., and Endo International plc account for nearly 40% of the global market share.
These companies are relying on mergers and acquisitions, co-promotion agreements, and developing novel treatments to sustain their position in the market. Below are a few recent strategies deployed by the leading market players:
- Acorda Therapeutics has two phase 3 and one phase 2 drug candidates for Parkinson’s disease as of December 2016.
- In February 2015, Endo International plc acquired Litha Healthcare Group in order develop advanced products using its expertise in specialty medicines.
- In December 2016, Hisamitsu Pharmaceutical Co., Inc. filed an application for a transdermal drug for the treatment of allergic rhinitis in Japan.
Buy Non-opioid Pain Patch Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=26168<ype=S
Mushrooming companies in regional markets are focusing on expanding their geographical reach through collaborations with leading pharmaceutical companies. Leading market players are supporting this move as it helps them gain access to local markets. However, it is hard to ignore the fact that this substantially increases the threat of new entrants and gives them a significant platform to proliferate the global market.
Asia Pacific hosts the highest number of regional players due to high prevalence of chronic pain and the history of opioid addiction. Some of the regional players in Asia Pacific include TEH SENG PharmaceuticalMfg. Co., Ltd., Teikoku Seiyaku Co., Ltd., and Hisamitsu Pharmaceutical Co., Inc.
Browse More Trending Reports by Transparency Market Research:
Assisted Living Market: https://www.transparencymarketresearch.com/assisted-living-market.html
Healthcare Education Solutions Market: https://www.transparencymarketresearch.com/healthcare-education-solutions-market.html
Nasal Decongestant Market: https://www.transparencymarketresearch.com/nasal-decongestant-market.html
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/